Pharmaceutical industry: Roche secures rights to cancer drugs in a billion-dollar deal

—·2d

The Swiss pharmaceutical company is hoping for a billion-dollar market with the blood cancer drug Bexobrutideg. The active ingredient could also be used for other diseases.

Channelssemiconductors, stocksCountriesgermany, europeCategoriesmergers-acquisitions

Open original source ↗

Published

6/8/2026, 5:49:05 AM

Fetched

6/8/2026, 6:07:11 AM

Confidence

60 / 100

Relevance

44 / 100

Trust

—

Language